Published 1987 | Version v1
Book

The use of /sup 125/I recombinant DNA/sub 125/ derived human erythropoietin (R-HuEPO) as a replacement for /sup 125/I human urinary epo as tracer antigen in a radioimmunoassay for human epo

  • 1. National Institute for Biological Standards and Control, Hampstead, London NW3 6RB (UK)
  • 2. Section of Haematology, Clinical Research Centre, Watford Road, Harrow, Middx. HA1 3UJ (UK)

Description

This paper represents evidence that in a radioimmunoassay for human erythropoietin, recombinant DNA derived human erythropoietin can replace highly purified human urinary erythropoietin in the preparation of radioiodinated tracer antigen

Additional details

Publishing Information

Publisher
Springer-Verlag New York Inc.
Imprint Place
New York, NY (USA)
Imprint Title
Molecular and cellular aspects of erythropoietin and erythropoiesis
Journal Page Range
p. 389-394.